Lobbying Filing Details
Total Spending
$390,000
Activities
3
Lobbyists
2
Gov't Entities
6
Filing Information
- Filing UUID:
b88a93a2-1a18-4e80-a9df-3a3377b5eb68- Type:
- Q4 - 4th Quarter - Report
- Period:
- 2025 - 4th Quarter (Oct 1 - Dec 31)
- Date Posted:
- January 20, 2026 at 5:26 PM
- Income:
- $0
- Expenses:
- $390,000
- Expense Method:
- A
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Deirdre Parsons
Registrant
ALNYLAM PHARMACEUTICALS, INC.
Cambridge, MassachusettsClient
ALNYLAM PHARMACEUTICALS, INC.
Pharmaceutical manufacturer
Massachusetts, United States of AmericaLobbying Activities (3)
Activity 1
Medicare/MedicaidIssues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act
Lobbyists (2)
- MS. DEIRDRE BRADFORD PARSONS
- CURTIS RHYNE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
PharmacyImplementation of The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (PL 116-94); issues related to drug pricing.
Lobbyists (2)
- MS. DEIRDRE BRADFORD PARSONS
- CURTIS RHYNE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
Trade (domestic/foreign)Issues relating to supply chain tariffs
Lobbyists (2)
- MS. DEIRDRE BRADFORD PARSONS
- CURTIS RHYNE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES